NASDAQ:LNSR LENSAR (LNSR) Stock Price, News & Analysis $5.44 +0.07 (+1.30%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$5.08▼$5.4550-Day Range$3.97▼$5.4452-Week Range$1.80▼$5.60Volume26,199 shsAverage Volume33,950 shsMarket Capitalization$62.02 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get LENSAR alerts: Email Address LENSAR MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside47.1% Upside$8.00 Price TargetShort InterestHealthy0.97% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.93Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.05 out of 5 starsMedical Sector401st out of 936 stocksSurgical & Medical Instruments Industry50th out of 101 stocks 3.5 Analyst's Opinion Consensus RatingLENSAR has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageLENSAR has received no research coverage in the past 90 days.Read more about LENSAR's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.97% of the float of LENSAR has been sold short.Short Interest Ratio / Days to CoverLENSAR has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in LENSAR has recently decreased by 6.39%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldLENSAR does not currently pay a dividend.Dividend GrowthLENSAR does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LNSR. Previous Next 2.7 News and Social Media Coverage News SentimentLENSAR has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for LENSAR this week, compared to 0 articles on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LENSAR insiders have not sold or bought any company stock.Percentage Held by Insiders38.52% of the stock of LENSAR is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions40.15% of the stock of LENSAR is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LENSAR's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of LENSAR is -3.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of LENSAR is -3.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLENSAR has a P/B Ratio of 1.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about LENSAR's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About LENSAR Stock (NASDAQ:LNSR)LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.Read More LNSR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LNSR Stock News HeadlinesJuly 21, 2024 | americanbankingnews.comLENSAR (NASDAQ:LNSR) vs. Teleflex (NYSE:TFX) Financial SurveyJuly 5, 2024 | investorplace.com3 Under-$10 Stocks With the Potential to Make You a MillionaireJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 23, 2024 | businesswire.comLENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads ConferenceMay 13, 2024 | finance.yahoo.comLENSAR, Inc. (NASDAQ:LNSR) Q1 2024 Earnings Call TranscriptMay 13, 2024 | seekingalpha.comLENSAR, Inc. (LNSR) Q1 2024 Earnings Call TranscriptMay 12, 2024 | finance.yahoo.comLENSAR, Inc. (NASDAQ:LNSR) Just Reported, And Analysts Assigned A US$8.00 Price TargetMay 11, 2024 | finance.yahoo.comLENSAR First Quarter 2024 Earnings: EPS Beats ExpectationsJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 9, 2024 | investorplace.comLNSR Stock Earnings: LENSAR Beats EPS, Beats Revenue for Q1 2024May 9, 2024 | finance.yahoo.comLENSAR Reports First Quarter 2024 Results and Provides Business UpdateMay 2, 2024 | businesswire.comLENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024May 1, 2024 | businesswire.comLENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 21, 2024 | morningstar.comLENSAR Inc Ordinary Shares LNSRApril 1, 2024 | businesswire.comLENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 7, 2024 | finance.yahoo.comLENSAR, Inc. (NASDAQ:LNSR) Just Reported Earnings, And Analysts Cut Their Target PriceMarch 5, 2024 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: 89bio (ETNB), UnitedHealth (UNH)March 5, 2024 | finance.yahoo.comLENSAR, Inc. (NASDAQ:LNSR) Q4 2023 Earnings Call TranscriptSee More Headlines Receive LNSR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LENSAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today7/26/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:LNSR CUSIPN/A CIK1320350 Webwww.lensar.com Phone888-536-7271FaxN/AEmployees130Year FoundedN/APrice Target and Rating Average Stock Price Target$8.00 High Stock Price Target$8.00 Low Stock Price Target$8.00 Potential Upside/Downside+47.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,380,000.00 Net Margins-27.57% Pretax Margin-27.57% Return on Equity-36.53% Return on Assets-17.67% Debt Debt-to-Equity RatioN/A Current Ratio4.06 Quick Ratio2.36 Sales & Book Value Annual Sales$42.16 million Price / Sales1.47 Cash FlowN/A Price / Cash FlowN/A Book Value$2.97 per share Price / Book1.83Miscellaneous Outstanding Shares11,400,000Free Float7,007,000Market Cap$62.02 million OptionableOptionable Beta0.65 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Nicholas T. Curtis (Age 67)President, CEO & Director Comp: $974.29kMr. Thomas R. Staab II (Age 56)CPA, CFO & Secretary Comp: $612.55kMr. Alan B. Connaughton (Age 52)Chief Operating Officer Comp: $650.62kMs. Kendra W. Wong (Age 44)Principal Accounting Officer Key CompetitorsDelcath SystemsNASDAQ:DCTHBeauty HealthNASDAQ:SKINCVRxNASDAQ:CVRXClearPoint NeuroNASDAQ:CLPTAccurayNASDAQ:ARAYView All CompetitorsInsidersGary M WinerBought 300 shares on 11/22/2023Total: $630.00 ($2.10/share)Gary M WinerBought 500 shares on 11/15/2023Total: $1,075.00 ($2.15/share)Gary M WinerBought 1,000 shares on 11/10/2023Total: $2,130.00 ($2.13/share)Gary M WinerBought 1,000 shares on 8/10/2023Total: $3,660.00 ($3.66/share)View All Insider Transactions LNSR Stock Analysis - Frequently Asked Questions How have LNSR shares performed this year? LENSAR's stock was trading at $3.51 at the beginning of the year. Since then, LNSR stock has increased by 55.0% and is now trading at $5.44. View the best growth stocks for 2024 here. How were LENSAR's earnings last quarter? LENSAR, Inc. (NASDAQ:LNSR) announced its quarterly earnings results on Thursday, May, 9th. The company reported ($0.19) earnings per share (EPS) for the quarter. The company earned $10.59 million during the quarter. LENSAR had a negative trailing twelve-month return on equity of 36.53% and a negative net margin of 27.57%. How do I buy shares of LENSAR? Shares of LNSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:LNSR) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENSAR, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENSAR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
